½ÃÀ庸°í¼­
»óǰÄÚµå
1594558

ºñ¸¸ ¼ö¼ú ±â±â ½ÃÀå : À¯Çüº°, ½Ã¼úº° - ¼¼°è ¿¹Ãø(2025-2030³â)

Obesity Surgery Devices Market by Type (Minimally Invasive Surgical Devices, Non-Invasive Surgical Devices), Procedure (Adjustable Gastric Banding, Biliopancreatic Diversion with Duodenal Switch, Gastric Bypass) - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 181 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

ºñ¸¸Áõ ¼ö¼ú ±â±â ½ÃÀåÀº 2023³â 40¾ï 7,000¸¸ ´Þ·¯·Î Æò°¡µÇ°í 2024³â¿¡´Â 43¾ï 9,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, CAGR 7.91%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 69¾ï 4,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

ºñ¸¸ ¼ö¼ú ±â±â ½ÃÀåÀÇ ¹üÀ§¿¡´Â À§ ¹êµå, À§ dz¼± ¹× ±âŸ ºñ¸¸ ¼ö¼ú±â±¸¿Í °°ÀÌ ºñ¸¸À¸·Î °íÅë¹Þ´Â »ç¶÷µéÀÇ Ã¼Áß °¨·®À» µ½±â À§ÇØ °í¾ÈµÈ ´Ù¾çÇÑ ÀÇ·á±â±¸°¡ Æ÷ÇԵ˴ϴÙ. ÀÌ·¯ÇÑ ±â±â´Â ÁÖ·Î ºñ¸¸ ¼ö¼ú¿¡ »ç¿ëµÇ¸ç ´ç´¢º´, °íÇ÷¾Ð, ½ÉÀ庴°ú °°Àº ºñ¸¸ °ü·Ã ÇÕº´ÁõÀÇ À¯º´·ü Áõ°¡·Î ÀÎÇØ Á¡Á¡ ´õ Çʼö ºÒ°¡°á ÇØÁö°í ÀÖ½À´Ï´Ù. ÁÖ¿ä ÃÖÁ¾»ç¿ëÀÚ´Â º´¿ø, ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ, Àü¹® Ŭ¸®´Ð µîÀÔ´Ï´Ù. ¿Ü°úÀû °³ÀÔ¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö°í º¸Çè Àû¿ëÀÌ °³¼±µÇ¸é¼­ ½ÃÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù. ÁÖ¿ä ¼ºÀå ¿äÀÎÀ¸·Î´Â ´ú ħ½ÀÀûÀÎ ½Ã¼úÀÇ ±â¼ú ¹ßÀü, Àü ¼¼°è ºñ¸¸À² Áõ°¡, °Ç°­ ¹× À£ºùÀ» ÃËÁøÇϱâ À§ÇÑ Á¤ºÎÀÇ Áö¿ø ÀÌ´Ï¼ÅÆ¼ºê µîÀÌ ÀÖ½À´Ï´Ù. ÇÑÆí, ÃֽŠºñÁî´Ï½º ±âȸ´Â ÃÖ¼Òħ½À ¼ö¼ú ±â±âÀÇ °³¹ß°ú ÀÇ·á ÀÎÇÁ¶ó °³¼±À¸·Î ÀÎÇÑ ½ÅÈï±¹ ½ÃÀå È®´ë¿¡ ÀÖ½À´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁØ ¿¬µµ[2023] 40¾ï 7,000¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ[2024] 43¾ï 9,000¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ[2030] 69¾ï 4,000¸¸ ´Þ·¯
CAGR(%) 7.91%

±×·¯³ª ³ôÀº ¼ö¼ú ºñ¿ë, ÀáÀçÀûÀÎ ¼ö¼ú ÈÄ ÇÕº´Áõ, ºñ¼ö¼úÀû Áö¹æ °¨¼Ò ¼Ö·ç¼ÇÀÇ Àαâ Áõ°¡ µîÀÌ ½ÃÀåÀÇ ¼ºÀåÀ» Á¦ÇÑÇÏ´Â ÁÖ¿ä ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¾ö°ÝÇÑ ±ÔÁ¦ »óȲ°ú ÀÌ·¯ÇÑ ¼ö¼úÀ» ¼öÇàÇϱâ À§ÇÑ ¼÷·ÃµÈ Àü¹®°¡¿¡ ´ëÇÑ ¿ä±¸ »çÇ×µµ À庮À¸·Î ÀÛ¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù. ¹Ý´ë·Î, ±â¼ú Çõ½ÅÀÇ Àü¸ÁÀº ¼ö¼ú ÀýÂ÷ÀÇ °­È­, º¸´Ù È¿°úÀûÀ̰í ȯÀÚ Ä£È­ÀûÀÎ ±â±âÀÇ °³¹ß, ¼ö¼ú °á°ú °³¼± ¹× ¼ö¼ú ÈÄ °ü¸® °ü¸®¸¦ À§ÇÑ AIÀÇ ÅëÇÕ¿¡ ÀÖ½À´Ï´Ù. ÀÇ·á±â±â Á¦Á¶¾÷ü¿Í ÀÇ·á ¼­ºñ½º Á¦°øÀÚ°¡ Çù·ÂÇÏ¿© ¿¬±¸¿Í ¹®È­Àû ¼ö¿ëÀ» ÃËÁøÇÏ¸é ½ÃÀå È®´ëÀÇ ±æÀ» ¿­ ¼ö ÀÖ½À´Ï´Ù. ºñ¸¸ ¼ö¼ú ±â±â ½ÃÀåÀº ¿þ¾î·¯ºí ±â¼ú, ½Ç½Ã°£ ¸ð´ÏÅ͸µ, ¸ÂÃãÇü ÀÇ·á Á¢±Ù ¹æ½ÄÀÇ Çõ½Å¿¡ Å« ¿µÇâÀ» ¹ÞÀ» ¼ö ÀÖ½À´Ï´Ù. Àü¹ÝÀûÀ¸·Î ½ÃÀåÀº °æÀïÀûÀÌ°í ¿ªµ¿ÀûÀ̸ç, Áö¼Ó°¡´ÉÇÑ ¼ºÀåÀ» º¸ÀåÇϰí Àü ¼¼°èÀûÀ¸·Î Áõ°¡ÇÏ´Â ºñ¸¸ ºÎ´ãÀ» ÇØ°áÇϱâ À§ÇØ Áö¼ÓÀûÀÎ ¿¬±¸¿Í ÀÇ·á µ¿Çâ ¹× ±ÔÁ¦ Ç¥ÁØ¿¡ ´ëÇÑ ÀûÀÀÀÌ ¿ä±¸µË´Ï´Ù.

½ÃÀå ¿ªÇÐ : ºü¸£°Ô ÁøÈ­ÇÏ´Â ºñ¸¸ ¼ö¼ú ±â±â ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

ºñ¸¸ ¼ö¼ú ±â±â ½ÃÀåÀº ¼ö¿ä¿Í °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ë¿¡ ÀÇÇØ º¯È­Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ º¯È­¸¦ ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº Á¤º¸¿¡ ÀÔ°¢ÇÑ ÅõÀÚ °áÁ¤À» ³»¸®°í, Àü·«ÀûÀÎ ÀÇ»ç°áÁ¤À» Á¤±³È­Çϸç, »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Æ÷ÂøÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Æ®·»µå¸¦ Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª Àü¹Ý¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ ÁÙÀÏ ¼ö ÀÖÀ¸¸ç, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë ¹× ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ÃËÁø¿äÀÎ
    • Àü ¼¼°è ºñ¸¸ Àα¸ Áõ°¡
    • üÁß °ü¸®¿Í ÇÇÆ®´Ï½º¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù.
    • ºñ¸¸ ¼ö¼ú°ú ÃÖ¼Òħ½À ¼ö¼úÀÇ Áõ°¡
  • ½ÃÀå ¾ïÁ¦¿äÀÎ
    • Á¦Ç° ¸®ÄÝ ¹× ÷´Ü ¼ö¼ú±â±¸ÀÇ °íºñ¿ë
  • ½ÃÀå ±âȸ
    • ºñ¸¸Áõ ¼ö¼ú ±â±âÀÇ ±â¼ú ¹ßÀü
    • ¼¼°è ÀÇ·á °ü±¤ÀÇ ºÎ»ó
  • ½ÃÀå °úÁ¦
    • ¼ö¼ú¿¡ µû¸¥ À§Çè, ÇÕº´Áõ ¹× ºÎÀÛ¿ë

Porter's Five Forces : ºñ¸¸ ¼ö¼ú ±â±â ½ÃÀåÀ» Ž»öÇÏ´Â Àü·«Àû µµ±¸

Porter's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ½ÃÀå »óȲÀÇ °æÀï »óȲÀ» ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Porter's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÇ °æÀï·ÂÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ Ž»öÇÒ ¼ö ÀÖ´Â ¸íÈ®ÇÑ ¹æ¹ýÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÀλçÀÌÆ®¸¦ ÅëÇØ ±â¾÷Àº °­Á¡À» Ȱ¿ëÇϰí, ¾àÁ¡À» ÇØ°áÇϰí, ÀáÀçÀûÀÎ µµÀüÀ» ÇÇÇϰí, º¸´Ù °­·ÂÇÑ ½ÃÀå Æ÷Áö¼Å´×À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : ºñ¸¸ ¼ö¼ú ±â±â ½ÃÀå¿¡¼­ ¿ÜºÎÀÇ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº ºñ¸¸ ¼ö¼ú ±â±â ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀο¡ ´ëÇÑ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇϸç, PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀû À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£µµ, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¼±Á¦ÀûÀÌ°í ´Éµ¿ÀûÀÎ ÀÇ»ç°áÁ¤À» ³»¸± Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® : ºñ¸¸ ¼ö¼ú ±â±â ½ÃÀå¿¡¼­ÀÇ °æÀï »óȲ ÆÄ¾Ç

ºñ¸¸ ¼ö¼ú ±â±â ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¼öÀÍ, °í°´ ±â¹Ý, ¼ºÀå·ü°ú °°Àº ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀïÀû À§Ä¡¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®Àº ½ÃÀåÀÇ ÁýÁßÈ­, ´ÜÆíÈ­, ÅëÇÕÀÇ Ãß¼¼¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖÀ¸¸ç, °ø±Þ¾÷ü´Â Ä¡¿­ÇÑ °æÀï ¼Ó¿¡¼­ ÀÚ½ÅÀÇ ÀÔÁö¸¦ °­È­ÇÒ ¼ö ÀÖ´Â Àü·«Àû ÀÇ»ç°áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ ÀλçÀÌÆ®¸¦ ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º : ºñ¸¸ ¼ö¼ú ±â±â ½ÃÀå¿¡¼­ÀÇ º¥´õÀÇ ¼º°ú Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â ºñ¸¸ ¼ö¼ú ±â±â ½ÃÀå¿¡¼­ º¥´õ¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº º¥´õÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±â¹ÝÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ºÎÇÕÇÏ´Â Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖÀ¸¸ç, 4°³ÀÇ »çºÐ¸éÀ¸·Î º¥´õ¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù. Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× Ãßõ : ºñ¸¸ ¼ö¼ú ±â±â ½ÃÀå¿¡¼­ ¼º°øÀÇ ±æ ã±â

ºñ¸¸ ¼ö¼ú ±â±â ½ÃÀåÀÇ Àü·«Àû ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ ÀÔÁö¸¦ °­È­ÇϰíÀÚ ÇÏ´Â ±â¾÷¿¡°Ô ÇʼöÀûÀÔ´Ï´Ù. ÁÖ¿ä ÀÚ¿ø, ¿ª·® ¹× ¼º°ú ÁöÇ¥¸¦ °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ¼ºÀå ±âȸ¸¦ ½Äº°ÇÏ°í °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀº °æÀï ȯ°æÀÇ µµÀü°úÁ¦¸¦ ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö Àִ ü°è¸¦ ±¸ÃàÇÒ ¼ö ÀÖµµ·Ï µµ¿ÍÁÝ´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõµµ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ : ½ÅÈï ½ÃÀå¿¡¼­ÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇϰí, ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡Çϸç, ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù°¢È­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä ¹ßÀü, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï »óȲÀ» öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú ¹ßÀü µîÀ» °ËÅäÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ÇâÈÄ ½ÃÀå ¼ºÀåÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÷´Ü ±â¼ú, ¿¬±¸ °³¹ß Ȱµ¿ ¹× Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

ÀÌÇØ°ü°èÀÚµéÀÌ ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖµµ·Ï ´ÙÀ½°ú °°Àº Áß¿äÇÑ Áú¹®¿¡ ´ëÇÑ ´äº¯µµ Á¦°øÇÕ´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå Àü¸ÁÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹®, Áö¿ªÀº ¾îµðÀΰ¡?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õÀÇ ½ÃÀå ÁøÀÔ ¹× ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±âȸ
    • °úÁ¦
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ¹ý·ü
    • ȯ°æ

Á¦6Àå ºñ¸¸ ¼ö¼ú ±â±â ½ÃÀå : À¯Çüº°

  • ÃÖ¼Òħ½À ¼ö¼ú ±â±â
    • ¾×¼¼¼­¸®
    • ½ºÅ×ÀÌÇà µð¹ÙÀ̽º
    • ºÀÇÕ ±â±¸
  • ºñħ½À¼º ¿Ü°ú¿ë ±â±â

Á¦7Àå ºñ¸¸ ¼ö¼ú ±â±â ½ÃÀå : ½Ã¼úº°

  • Á¶Àý¼ºÀ§¹êµù
  • ½ÊÀÌÁöÀå ½ºÀ§Ä¡¿¡ ÀÇÇÑ ´ãÃé ¿ìȸ¼ú
  • À§¿ìȸ¼ú
  • ¹Ì´Ï À§¿ìȸ¼ú
  • ºñħ½À¼º ºñ¸¸ ¼ö¼ú
  • ºñ¸¸ ¼ö¼ú Àç¼ö¼ú
  • À§¼Ò¸ÅÀýÁ¦¼ú

Á¦8Àå ¾Æ¸Þ¸®Ä«ÀÇ ºñ¸¸ ¼ö¼ú ±â±â ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦9Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ºñ¸¸ ¼ö¼ú ±â±â ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦10Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ºñ¸¸ ¼ö¼ú ±â±â ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®
  • ¿µ±¹

Á¦11Àå °æÀï »óȲ

  • ½ÃÀå Á¡À¯À² ºÐ¼® 2023
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸®½ºÆ®

  • Agency for Medical Innovation
  • Allergan Inc. by AbbVie Inc.
  • Apollo Endosurgery, Inc.
  • B. Braun Melsungen AG
  • Bariatec Corporation
  • Cousin Biotech
  • Intuitive Surgical Inc.
  • Johnson & Johnson Services Inc.
  • Medtronic PLC
  • Olympus Corporation
  • ReShape Lifesciences, Inc.
  • Spatz FGIA, Inc.
  • Standard Bariatrics, Inc.
  • Stryker Corporation
  • TransEnterix Surgical, Inc.
ksm 24.11.28

The Obesity Surgery Devices Market was valued at USD 4.07 billion in 2023, expected to reach USD 4.39 billion in 2024, and is projected to grow at a CAGR of 7.91%, to USD 6.94 billion by 2030.

The scope of the obesity surgery devices market encompasses a range of medical devices designed to aid in weight loss for individuals suffering from obesity, including gastric bands, gastric balloons, and other bariatric surgical tools. These devices are primarily used in bariatric surgeries, which are increasingly essential due to the rising prevalence of obesity-related complications like diabetes, hypertension, and cardiac problems. The key end-users include hospitals, ambulatory surgical centers, and specialty clinics. Increasing awareness about surgical interventions and improved insurance coverage are driving the market. Key growth factors include technological advancements in less invasive procedures, growing rates of obesity globally, and supportive government initiatives promoting health and wellness. Meanwhile, the latest opportunities lie in the development of minimally invasive surgical devices and expanding markets in developing regions due to improving healthcare infrastructure.

KEY MARKET STATISTICS
Base Year [2023] USD 4.07 billion
Estimated Year [2024] USD 4.39 billion
Forecast Year [2030] USD 6.94 billion
CAGR (%) 7.91%

However, market growth is limited by high surgical costs, potential post-surgical complications, and the growing popularity of non-surgical fat loss solutions, which pose a significant challenge. Additionally, the stringent regulatory landscape and the requirement for skilled professionals to conduct these surgeries can act as barriers. Conversely, innovation prospects lie in the enhancement of surgical techniques, development of more effective and patient-friendly devices, and integration of AI for improved surgical outcomes and management of post-operative care. Collaborations between medical device companies and healthcare providers to foster research and cultural acceptance may pave the way for market expansion. The obesity surgery devices market could see a profound impact from innovations in wearable technology, real-time monitoring, and personalized medicine approaches. Overall, the market is competitive and dynamic, demanding continuous research and adaptation to healthcare trends and regulatory standards to ensure sustainable growth and address the increasing global burden of obesity.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Obesity Surgery Devices Market

The Obesity Surgery Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Prevalence of obese population worldwide
    • Growing awareness regarding weight management and fitness
    • Growing number of bariatric surgeries and minimally invasive procedures
  • Market Restraints
    • Product recall and high cost of advanced surgery devices
  • Market Opportunities
    • Technological advancements in obesity surgery devices
    • Rise of medical tourism worldwide
  • Market Challenges
    • Associated risks, complications and side effects of surgery

Porter's Five Forces: A Strategic Tool for Navigating the Obesity Surgery Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Obesity Surgery Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Obesity Surgery Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Obesity Surgery Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Obesity Surgery Devices Market

A detailed market share analysis in the Obesity Surgery Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Obesity Surgery Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Obesity Surgery Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Obesity Surgery Devices Market

A strategic analysis of the Obesity Surgery Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Obesity Surgery Devices Market, highlighting leading vendors and their innovative profiles. These include Agency for Medical Innovation, Allergan Inc. by AbbVie Inc., Apollo Endosurgery, Inc., B. Braun Melsungen AG, Bariatec Corporation, Cousin Biotech, Intuitive Surgical Inc., Johnson & Johnson Services Inc., Medtronic PLC, Olympus Corporation, ReShape Lifesciences, Inc., Spatz FGIA, Inc., Standard Bariatrics, Inc., Stryker Corporation, and TransEnterix Surgical, Inc..

Market Segmentation & Coverage

This research report categorizes the Obesity Surgery Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Minimally Invasive Surgical Devices and Non-Invasive Surgical Devices. The Minimally Invasive Surgical Devices is further studied across Accessories, Stapling Devices, and Suturing Devices.
  • Based on Procedure, market is studied across Adjustable Gastric Banding, Biliopancreatic Diversion with Duodenal Switch, Gastric Bypass, Mini-Gastric Bypass, Non-Invasive Bariatric Surgery, Revision Bariatric Surgery, and Sleeve Gastrectomy.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Prevalence of obese population worldwide
      • 5.1.1.2. Growing awareness regarding weight management and fitness
      • 5.1.1.3. Growing number of bariatric surgeries and minimally invasive procedures
    • 5.1.2. Restraints
      • 5.1.2.1. Product recall and high cost of advanced surgery devices
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in obesity surgery devices
      • 5.1.3.2. Rise of medical tourism worldwide
    • 5.1.4. Challenges
      • 5.1.4.1. Associated risks, complications and side effects of surgery
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Obesity Surgery Devices Market, by Type

  • 6.1. Introduction
  • 6.2. Minimally Invasive Surgical Devices
    • 6.2.1. Accessories
    • 6.2.2. Stapling Devices
    • 6.2.3. Suturing Devices
  • 6.3. Non-Invasive Surgical Devices

7. Obesity Surgery Devices Market, by Procedure

  • 7.1. Introduction
  • 7.2. Adjustable Gastric Banding
  • 7.3. Biliopancreatic Diversion with Duodenal Switch
  • 7.4. Gastric Bypass
  • 7.5. Mini-Gastric Bypass
  • 7.6. Non-Invasive Bariatric Surgery
  • 7.7. Revision Bariatric Surgery
  • 7.8. Sleeve Gastrectomy

8. Americas Obesity Surgery Devices Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Obesity Surgery Devices Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Obesity Surgery Devices Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Agency for Medical Innovation
  • 2. Allergan Inc. by AbbVie Inc.
  • 3. Apollo Endosurgery, Inc.
  • 4. B. Braun Melsungen AG
  • 5. Bariatec Corporation
  • 6. Cousin Biotech
  • 7. Intuitive Surgical Inc.
  • 8. Johnson & Johnson Services Inc.
  • 9. Medtronic PLC
  • 10. Olympus Corporation
  • 11. ReShape Lifesciences, Inc.
  • 12. Spatz FGIA, Inc.
  • 13. Standard Bariatrics, Inc.
  • 14. Stryker Corporation
  • 15. TransEnterix Surgical, Inc.
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦